• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804350-18
Medical Device Problem Codes Failure to Advance (2524); Device Dislodged or Dislocated (2923); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/05/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A visual and dimensional inspection was performed on the returned device.The reported material deformation (stent damage) was confirmed.The reported failure to advance could not be replicated in a testing environment as it was related to operational context of the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported failure to advance appears to be related to the operational context of the procedure as it is likely that the sds interacted with the lesion during advancement resulting in the reported failure to advance and subsequent stent dislodgement/dislocated (observed during returned device analysis) and material deformation.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Event or Problem Description
It was reported that the procedure was to treat a 90% stenosed lesion in circumflex artery with calcification and tortuosity.The 3.50x18mm xience skypoint stent delivery system (sds) was advanced to the target lesion; however, the stent met with resistance with the heavily calcified lesion and failed to cross.When the sds was removed from anatomy and the stent struts were noted to be flared.Additional pre-dilatation was performed and a new xience skypoint stent was used to complete the procedure.No additional information was provided return device analysis found the proximal end of the stent implant was located 1mm distal from its original crimped position as the stent implant had moved distally on the balloon.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17278611
Report Number2024168-2023-07189
Device Sequence Number12033479
Product Code NIQ
UDI-Device Identifier08717648233401
UDI-Public08717648233401
Combination Product (Y/N)Y
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 07/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/08/2026
Device Model Number1804350-18
Device Catalogue Number1804350-18
Device Lot Number3012341
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/30/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/12/2023
Initial Report FDA Received Date07/07/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/19/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-